Market cap
$0 Mln
Revenue (TTM)
$2 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 1.00 | 64.26 | 72.82 | 17.37 | -172.79 |
| Net Profit | 24.39 | 69.25 | 57.60 | 13.13 | -187.75 |
| EPS | 31.50 | 76.76 | 61.94 | 16.50 | -- |
| Book Value | -- | -- | -90.12 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-23 | Dec-22 |
| EBIT-Margin
| -- | -- | -630.85 | -- | -- |
| Net Margin
| -- | -- | -972.24 | -- | -- |
| Return on equity
| 184.41 | 318.81 | -930.73 | -180.64 | 886.06 |
| Return on Capital
| 194.74 | 90.75 | -- | -175.29 | 878.30 |
| Return on Assets
| 180.18 | 28.38 | -102.22 | -125.24 | 766.91 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.02 | 0.03 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
--
|
-175.29
|
878.30
|
-118.79
|
-93.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-930.73
Lower than Peers by 890.33
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
-930.73
|
-180.64
|
886.06
|
-152.18
|
1,230.36
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-102.22
Lower than Peers by 71.24
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
-102.22
|
-125.24
|
766.91
|
-101.13
|
-252.92
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
-630.85
Lower than Peers by 547.23
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
-630.85
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
-972.24
Lower than Peers by 879.57
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
-972.24
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Lower than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
EBIT Growth
72.82
Higher than Peers by 73.62
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
72.82
|
53.30
|
-25.02
|
-77.40
|
-34.94
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
57.60
Higher than Peers by 64.90
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
57.60
|
-106.29
|
1,093.68
|
-63.55
|
-55.86
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
EPS Growth
61.94
Higher than Peers by 47.29
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
61.94
|
-1.06
|
10.36
|
-0.77
|
-0.02
|
|
Peer Median
|
14.65
|
--
|
--
|
--
|
--
|
Book Value Growth
-95.91
Lower than Peers by 85.73
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
-95.91
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
--
|
0.02
|
0.03
|
--
|
-1.21
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
--
|
0.02
|
0.02
|
--
|
-1.21
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.66
Lower than Peers by 5.15
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
0.66
|
1.06
|
3.62
|
11.96
|
0.31
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
0.66
Lower than Peers by 5.04
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
0.66
|
--
|
3.62
|
--
|
--
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
0.92
Higher than Peers by 3.01
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
0.92
|
--
|
-0.11
|
-55.22
|
-16.75
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
0.11
Higher than Peers by 0.04
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
0.11
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
--
|
-6.94
|
-4.75
|
--
|
36.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
--
|
661.69
|
417.99
|
798.52
|
1,160.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
--
|
-0.07
|
0.00
|
-0.08
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.00
Lower than Peers by 5.18
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
0.00
|
0.67
|
0.01
|
0.05
|
--
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.53
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
0.53
|
0.08
|
0.55
|
1.58
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
0
Lower than Peers by 146
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Neximmune Inc (NEXI)
|
0
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|